Actively Recruiting
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Led by The Methodist Hospital Research Institute · Updated on 2025-12-18
854
Participants Needed
1
Research Sites
307 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This phase III clinical trial will evaluate the impact on survival of adding chaplain-provided spiritual care or psychotherapy/meditation to standard-of-care (SOC) and palliative measures, plus chemotherapy if recommended, and comparing it with SOC and palliative measures, plus chemotherapy if recommended, in patients with non-curative malignancies. The Palliative Care Department at Houston Methodist Hospital provides essential services to patients diagnosed with advanced cancer by sharing information and resources about symptom management, pain treatment and planning for the future. It is also recognized that chaplaincy-based spiritual care of patients can be a valuable part of interdisciplinary interventions in oncology.
CONDITIONS
Official Title
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient provides written informed consent for the trial.
- Male or female aged 18 years or older at the time of consent.
- Histologically confirmed metastatic disease with life expectancy of one year or less.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3.
- Willing and able to comply with the trial protocol, including scheduled visits and interventions.
You will not qualify if you...
- Known psychiatric or substance abuse disorders that interfere with cooperation with trial requirements.
- Mobility limitations that interfere with cooperation with trial requirements.
- Confirmed positive pregnancy test in women of childbearing potential.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Houston Methodist Neal Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
H
Hanh Mai, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here